Published in Med Microbiol Immunol on December 29, 2013
Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med (2006) 6.00
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ (2000) 5.42
Control of Chagas disease. World Health Organ Tech Rep Ser (2002) 4.00
Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guérin vaccination. J Immunol (1999) 2.94
Chagas disease: a new worldwide challenge. Nature (2010) 2.65
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol (2002) 1.98
Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol (1997) 1.93
Overview of interleukin-2 function, production and clinical applications. Cytokine (2004) 1.86
Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiol (2009) 1.63
Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis. Rev Sci Tech (1993) 1.37
Chagas disease: 100 years after its discovery. A systemic review. Acta Trop (2010) 1.36
Echocardiography in Chagas heart disease. Circulation (2007) 1.32
Persistence of the immune response induced by BCG vaccination. BMC Infect Dis (2008) 1.29
BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size. Int J Tuberc Lung Dis (2000) 1.26
The immune response to BCG vaccination of newborns. Ann N Y Acad Sci (2005) 1.25
Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest (1996) 1.22
Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J (2004) 1.19
Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. Eur J Cancer (2005) 1.08
The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc (2001) 1.07
BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro. Immunology (2007) 1.03
Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol (2003) 0.99
Autoimmunity. Adv Parasitol (2011) 0.96
Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin Exp Immunol (2007) 0.96
The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. Vaccine (2008) 0.96
Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis. Clin Vaccine Immunol (2009) 0.93
Update on Chagas heart disease on the first centenary of its discovery. Rev Esp Cardiol (2009) 0.92
Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection. J Clin Microbiol (2005) 0.86
Autoimmunity in Chagas heart disease. Int J Parasitol (2001) 0.84
Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes. Immunology (1991) 0.83
Dynamics of Lymphocyte Populations during Trypanosoma cruzi Infection: From Thymocyte Depletion to Differential Cell Expansion/Contraction in Peripheral Lymphoid Organs. J Trop Med (2012) 0.80
Improved outcome of Trypanosoma cruzi infection in rats following treatment in early life with suspensions of heat-killed environmental Actinomycetales. Vaccine (2006) 0.80
Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes. Immunology (1992) 0.80
Increased immunoglobulin secretion by B lymphocytes from Trypanosoma cruzi infected mice after B lymphocytes-natural killer cell interaction. Parasite Immunol (2001) 0.80
Trypanosoma cruzi antigen that interacts with the beta1-adrenergic receptor and modifies myocardial contractile activity. Mol Biochem Parasitol (2003) 0.79
Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease. Rev Esp Cardiol (Engl Ed) (2013) 0.78
Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Int J Lepr Other Mycobact Dis (1994) 0.78
Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Braz J Med Biol Res (1997) 0.78
The effect of interleukin-2 on parasitemia and myocarditis in experimental Chagas' disease. J Protozool (1989) 0.77
Antibodies against the Trypanosoma cruzi ribosomal P proteins induce apoptosis in HL-1 cardiac cells. Int J Parasitol (2011) 0.77
Chronic Chagas disease with cardiodigestive involvement and the TcVI infective form of Trypanosoma cruzi. A case report. Parasitol Int (2012) 0.77
BCG-induced resistance in Trypanosoma cruzi experimental infections. Tropenmed Parasitol (1981) 0.76
[Risk stratification in Chagas disease]. Rev Esp Cardiol (Engl Ed) (2012) 0.76
Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes. Immunology (1992) 0.76
Trypanosoma cruzi immunosuppressive factor decreases the interleukin-2 mRNA level in cultured normal activated human lymphocytes. Infect Immun (1995) 0.76
Defective production of interleukin 2 in patients with Chagas' disease. Purified IL-2 augments in vitro response in patients with chagasic cardiomyopathy. Mem Inst Oswaldo Cruz (1997) 0.76
Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Cytokine Growth Factor Rev (2007) 1.66
The value of molecular studies for the diagnosis of congenital Chagas disease in northeastern Argentina. Am J Trop Med Hyg (2008) 0.96
Chagasic thymic atrophy does not affect negative selection but results in the export of activated CD4+CD8+ T cells in severe forms of human disease. PLoS Negl Trop Dis (2011) 0.92
A multifaceted analysis of immune-endocrine-metabolic alterations in patients with pulmonary tuberculosis. PLoS One (2011) 0.91
Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL/6 mice is partly reverted by lipopolysaccharide pretreatment. FEMS Immunol Med Microbiol (2004) 0.87
A clinical correlate of the dysregulated immunoendocrine response in human tuberculosis. Neuroimmunomodulation (2010) 0.87
Impaired immune responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance. Neuroimmunomodulation (2007) 0.85
TNF-α is involved in the abnormal thymocyte migration during experimental Trypanosoma cruzi infection and favors the export of immature cells. PLoS One (2012) 0.84
The impact of infectious diseases upon neuroendocrine circuits. Neuroimmunomodulation (2009) 0.84
The dual face of central nervous system tuberculosis: a new Janus Bifrons? Tuberculosis (Edinb) (2013) 0.82
Immunoendocrinology of the thymus in Chagas disease. Neuroimmunomodulation (2011) 0.82
Trans-sialidase from Trypanosoma cruzi enhances the adhesion properties and fibronectin-driven migration of thymocytes. Microbes Infect (2013) 0.81
Benznidazole, a drug used in Chagas' disease, ameliorates LPS-induced inflammatory response in mice. Life Sci (2004) 0.81
HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection. Ann Clin Biochem (2006) 0.80
Maternal immunization with actinomycetales immunomodulators reduces parasitemias in offspring challenged with Trypanosoma cruzi. Immunotherapy (2011) 0.79
Association of leprosy with HLA-DRB1 in an Argentinean population. Ann Clin Biochem (2008) 0.79
Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids. Int Immunol (2013) 0.79
Changes in the immune and endocrine responses of patients with pulmonary tuberculosis undergoing specific treatment. Ann N Y Acad Sci (2012) 0.79
Beneficial effects of benznidazole during an infectious-based situation of systemic inflammatory response: cecal ligation and puncture. Am J Trop Med Hyg (2008) 0.79
Cardiovascular risk factors in chronic Chagas' disease are associated with a different profile of putative heart-pathogenic antibodies. FEMS Immunol Med Microbiol (2006) 0.79
Benznidazole blocks NF-kappaB activation but not AP-1 through inhibition of IKK. Mol Immunol (2010) 0.79
Novel cytostatic activity of the trypanocidal drug Benznidazole. Int Immunopharmacol (2009) 0.78
Levels of inflammatory cytokines, adrenal steroids, and mRNA for GRα, GRβ and 11βHSD1 in TB pleurisy. Tuberculosis (Edinb) (2013) 0.78
Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons. PLoS One (2012) 0.78
Humoral immune response against P2β from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage. Am J Trop Med Hyg (2011) 0.78
The common mycobacterial antigens and their importance in the treatment of disease. Curr Pharm Des (2009) 0.78
Preparation and characterization of a Staphylococcus aureus capsular polysaccharide-protein conjugate prepared by a low cost technique: a proof-of-concept study. Appl Biochem Biotechnol (2014) 0.77
The adrenal steroid response during tuberculosis and its effects on the mycobacterial-driven IFN-gamma production of patients and their household contacts. Ann N Y Acad Sci (2009) 0.77
Impact of Taenia solium neurocysticercosis upon endocrine status and its relation with immuno-inflammatory parameters. Int J Parasitol (2011) 0.77
TGF-β neutralization abrogates the inhibited DHEA production mediated by factors released from M. tuberculosis-stimulated PBMC. Ann N Y Acad Sci (2012) 0.77
Chagas disease, a risk factor for high blood pressure. Blood Press (2014) 0.77
Tumor necrosis factor-α regulates glucocorticoid synthesis in the adrenal glands of Trypanosoma cruzi acutely-infected mice. the role of TNF-R1. PLoS One (2013) 0.76
Favorably orienting recombinant proteins to develop amperometric biosensors to diagnose Chagas' disease. Anal Biochem (2010) 0.76
Reciprocal influences between leptin and glucocorticoids during acute Trypanosoma cruzi infection. Med Microbiol Immunol (2013) 0.75
[Metabolic abnormalities in young offsprings of parents with essential hypertension]. Medicina (B Aires) (2013) 0.75
Immunotherapy for the prevention of myointimal hyperplasia after experimental balloon injury of the rat carotid artery. Angiology (2010) 0.75
Beneficial effects of immunotherapy with extracts derived from Actinomycetales on rats with spontaneous obesity and diabetes. Immunotherapy (2012) 0.75
Cyclophosphamide adjuvant arthritis in Trypanosoma cruzi infected rats with inflammatory cytokine effects. J Rheumatol (2003) 0.75